Keyword Connections

anti-bacterial agents / administration & dosage*

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

22

1 A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

2 Is monotherapy for febrile neutropenia still a viable alternative?

3 New trends in patient management: risk-based therapy for febrile patients with neutropenia

4 Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship

5 Azithromycin in non-gonococcal urethritis

6 Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review

7 Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection

8 The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection

9 Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications

10 Levofloxacin cures experimental pneumonic plague in African green monkeys

11 Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men

12 Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults

13 Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients

14 Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial

15 Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial

16 Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

17 Suboptimal aminoglycoside dosing in critically ill patients

18 Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity

19 Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990

20 Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen

21 Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital

22 Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review